Overview
FDA & Trial Timeline
1 eventHepaGam B: FDA approved
Prevention of hepatitis B recurrence following liver transplantation in HBsAG-positive liver transplant patients
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
3 availableAminocaproic Acid
Fibrinolytic bleeding may frequently be associated with surgical complications following portacaval shunt
MAVYRET
MAVYRET is indicated for the treatment of adult and pediatric patients 3 years and older with acute or chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5 or 6 infection without cirrhosis or with c…
MAVYRET is indicated for the treatment of adult and pediatric patients 3 years and older with acute or chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5 or 6 infection without cirrhosis or with compensated cirrhosis (Child-Pugh A)
HepaGam B
Prevention of hepatitis B recurrence following liver transplantation in HBsAG-positive liver transplant patients
Clinical Trials
View all trials with filters →No actively recruiting trials found for Hepatitis B reinfection following liver transplantation at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Financial Resources
1 resourcesTravel Grants
No travel grants are currently matched to Hepatitis B reinfection following liver transplantation.
Community
No community posts yet. Be the first to share your experience with Hepatitis B reinfection following liver transplantation.
Start the conversation →Latest news about Hepatitis B reinfection following liver transplantation
1 articlesCaregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Hepatitis B reinfection following liver transplantation
Which specialists treat Hepatitis B reinfection following liver transplantation?
2 specialists and care centers treating Hepatitis B reinfection following liver transplantation are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.
What treatment and support options exist for Hepatitis B reinfection following liver transplantation?
2 patient support programs are currently tracked on UniteRare for Hepatitis B reinfection following liver transplantation. See the treatments and support programs sections for copay assistance, eligibility, and contact details.